Results 101 to 110 of about 2,249 (191)

Asthma-COPD Overlap Syndrome : a review of current knowledge and future directions [PDF]

open access: yes, 2017
Asthma and chronic obstructive pulmonary disease are common diseases both characterised by airflow obstruction. Over recent decades the prevailing belief was that asthma and COPD were distinct diseases that can be easily distinguished and require ...
Johnston, Sebastian Lennox   +1 more
core  

Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: results from two phase III, randomized, double-blinded, placebo-controlled trials [PDF]

open access: yes, 2022
Lebrikizumab, a high-affinity IgG-4 monoclonal antibody targeting interleukin (IL)-13, selectively prevents the formation of the IL-13Ra1/IL-4Ra heterodimer receptor signalling complex.
Blauvelt, Andrew   +10 more
core   +1 more source

A review of standard pharmacological therapy for adult asthma - Steps 1 to 5 [PDF]

open access: yes, 2015
The aim of pharmacological therapy for asthma is to improve symptoms and lung function and minimise the risk of asthma attacks. The intensity of treatment is based on the level of asthma control and the potential risk of future deterioration.
Patel, Mitesh Dilipkumar Kantilal   +1 more
core   +2 more sources

Efficacy and safety of lebrikizumab for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis

open access: yesFrontiers in Pharmacology
BackgroundLebrikizumab, an IL-13 immunomodulator, has shown recommendable effectiveness and safety in clinical studies for the treatment of moderate-to-severe atopic dermatitis (AD) in adolescents and adults.ObjectiveTo evaluate the efficacy and safety ...
Jinger Lin   +5 more
doaj   +1 more source

Immunoglobulin G; structure and functional implications of different subclass modifications in initiation and resolution of allergy. [PDF]

open access: yes, 2017
IgE and not IgG is usually associated with allergy. IgE lodged on mast cells in skin or gut and basophils in the blood allows for the prolonged duration of allergy through the persistent expression of high affinity IgE receptors.
Amlot P. L.   +18 more
core   +2 more sources

Behandlung von juvenilem bullösem Pemphigoid mit Lebrikizumab [PDF]

open access: yesJ Dtsch Dermatol Ges
Wittenberg M   +6 more
europepmc   +2 more sources

Allergy in severe asthma [PDF]

open access: yes, 2017
It is well recognized that atopic sensitisation is an important risk factor for asthma, both in adults and in children. However, the role of allergy in severe asthma is still under debate. The term "Severe Asthma" encompasses a highly heterogeneous group
Bakirtas, Arzu   +12 more
core   +1 more source

Lebrikizumab improves head/neck/face dermatitis and erythema and does not increase treatment-emergent adverse events of head/neck/face erythema in patients with moderate-to-severe atopic dermatitis

open access: yesJournal of Dermatological Treatment
Purpose of the study Head, neck (HN), and face involvement in atopic dermatitis (AD) poses a major psychological burden and can be challenging to effectively treat.
Jenny E. Murase   +14 more
doaj   +1 more source

Asma [PDF]

open access: yes, 2014
Dissertação para obtenção do grau de Mestre no Instituto Superior de Ciências da Saúde Egas MonizA asma é um conjunto de condições heterogéneas que resulta na obstrução reversível dos brônquios, e é caracterizada por hiper-reatividade e inflamação das ...
Martins, Henrique Gabriel de Oliveira
core  

Protein engineering to increase the potential of a therapeutic antibody Fab for long-acting delivery to the eye [PDF]

open access: yes, 2017
To date, ocular antibody therapies for the treatment of retinal diseases rely on injection of the drug into the vitreous chamber of the eye. Given the burden for patients undergoing this procedure, less frequent dosing through the use of long-acting ...
Andersen, Nisana   +18 more
core  

Home - About - Disclaimer - Privacy